Cases & Deals

Chemical company invests in EdeniQ

Clients Chemical company

Jones Day represented a leading refining and chemicals company as lead investor in connection with the purchase of Series C Preferred Stock in a private placement by EdeniQ, Inc., a developer of proprietary, cutting edge solutions for the global biofuels industry. Co-investors included Morgan Stanley, Cyrus Capital Partners, Kleiner Perkins, Draper Fischer Jurvetson, and The Angeleno Group.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.